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Abstract
We conducted a systematic review of human trials examining the effects of dietary phytochemicals on Nrf2 activation. In 
accordance with the PRISMA guidelines, Medline, Embase and CAB abstracts were searched for articles from inception 
until March 2020. Studies in adult humans that measured Nrf2 activation (gene or protein expression changes) following 
ingestion of a phytochemical, either alone or in combination were included. The study was pre-registered on the Prospero 
database (Registration Number: CRD42020176121). Twenty-nine full-texts were retrieved and reviewed for analysis; of these, 
eighteen were included in the systematic review. Most of the included participants were healthy, obese or type 2 diabetics. 
Study quality was assessed using the Cochrane Collaboration Risk of Bias Assessment tool. Twelve different compounds were 
examined in the included studies: curcumin, resveratrol and sulforaphane were the most common (n = 3 each). Approximately 
half of the studies reported increases in Nrf2 activation (n = 10); however, many were of poor quality and had an unclear or 
high risk of bias. There is currently limited evidence that phytochemicals activate Nrf2 in humans. Well controlled human 
intervention trials are needed to corroborate the findings from in vitro and animal studies.
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Introduction
Phytochemicals, defined as plant metabolites, are ubiquitous 
in the human diet [1]. Indeed, several thousand different phy-
tochemicals have been identified in commonly consumed 
plants [2]. These phytochemicals can be sub-divided into 
four higher order classes, based on their chemical structure: 
phenols and polyphenols, terpenoids, alkaloids, and sulphur 
containing compounds [2]. Although not deemed essential 
for health, numerous longitudinal studies report positive 
associations between the intake of phytochemicals and 
health, including a lowered risk of cardiovascular, neurode-
generative, and metabolic disease [3–8]. For example, in a 
large study of more than 5000 Finnish adults, higher intakes 
of flavonoids, the major class of polyphenols in the human 
diet, was associated with a reduced risk of heart disease 
[8]. Similarly, intake of anthocyanins, polyphenols present 
in many fruits, was associated with a reduced risk of myo-
cardial infarction in ≥ 90,000 middle-older age women [7]. 
These findings have sparked significant interest in elucidat-
ing the wider health promoting potential of phytochemicals 
and resolving the molecular bases of such effects.
Several putative mechanisms for the potential health pro-
moting effects of phytochemicals have been postulated, with 
their function as antioxidants receiving the most attention. 
Although many different definitions of antioxidants exist, 
they are recognized as agents that donate electrons to, and 
thereby stabilize, oxidants to prevent them from oxidizing 
other molecules [9, 10]. While some degree of oxidation is 
an important and necessary biological process, an excessive 
increase in reactive species (also referred to as free radicals) 
that exceeds antioxidant capacity leads to oxidative stress 
and the associated oxidative damage to proteins, lipids, 
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DNA and other molecules [10, 11]. Hence, excess produc-
tion of reactive species is implicated in the initiation and 
progression of several diseases [12, 13]. To protect against 
oxidative damage, cells are endowed with an antioxidant 
defense system, which includes various antioxidant enzymes 
including superoxide dismutase, catalase, and glutathione 
peroxidase [14]. Under normal conditions, endogenous anti-
oxidants maintain cellular redox state by effectively scav-
enging radicals [9, 10]. However, exposure to a stressor that 
augments oxidant production (e.g., chronic disease, exer-
cise, pollutants, injury) can overwhelm endogenous cellular 
antioxidant defenses [14]. In such circumstances, exogenous 
phytochemicals or dietary antioxidants like vitamin C and 
E (collectively referred to as non-enzymatic antioxidants) 
might be needed to maintain cellular redox status and offset 
protein, lipid, and DNA oxidation [9, 11].
The antioxidant effects of phytochemicals have been 
largely ascribed to radical scavenging [15, 16]. Indeed, phy-
tochemicals, including curcumin, resveratrol, and querce-
tin have been shown to scavenge reactive species in vitro 
[17, 18]. In human studies, direct measurement of reactive 
species is more challenging due to their high reactivity and 
short biological half-lives [19]. Instead, antioxidant effects 
are often inferred by measuring tissue concentrations of oxi-
dation products, such as protein carbonyls or F2-isoprostanes 
[19, 20]. Although findings are inconsistent [21], there is 
evidence that phytochemicals can lower systemic or cellular 
levels of lipid or protein oxidation in humans, suggestive of 
antioxidant effects [22–25].
Although the radical scavenging observed in vitro is often 
extrapolated and used to explain the antioxidant effects of 
phytochemicals in vivo, this contention has been questioned 
[26]. Perhaps the best evidence to undermine direct antioxi-
dant effects of phytochemicals in vivo is the fact that most 
phytochemicals are extensively metabolized and have poor 
bioavailability, such that systemic concentrations typically 
reached after ingestion (~ 1 µmol/L) are significantly lower 
than the concentrations required to directly scavenge reac-
tive species [26–28]. Instead, the major mechanism for the 
antioxidant or biological effects of phytochemicals in vivo is 
increasingly being attributed to their induction of the redox 
sensitive transcription factor, nuclear erythroid 2-related fac-
tor 2 (Nrf2) [26, 29].
In response to homeostatic challenges Nrf2 upregu-
lates ~ 250 cytoprotective genes, many of which code for 
proteins with antioxidant, anti-inflammatory or phase 2 
detoxifying functions [30]. Nrf2 is primarily regulated by 
cysteine-rich kelch-like ECH associated protein 1 (Keap-
1), which sequesters Nrf2 in the cytosol through continual 
ubiquination [31, 32]. By reacting with cysteine residues on 
Keap-1, reactive species or electrophiles remove its repres-
sive functions and enable Nrf2 to accumulate [33, 34]. After 
dissociating from Keap-1, Nrf2 translocates to the nucleus 
where it forms a heterodimer with musculoaponeurotic 
fibrosarcoma proteins to activate the antioxidant response 
element (ARE)-DNA sequence (also referred to as the elec-
trophile response element) [32, 35].
The various mechanisms by which phytochemicals acti-
vate Nrf2 are still being unraveled; however, a few of these 
have been well-described in the literature. Indeed, two prom-
inent mechanisms are that phytochemicals initiate the Nrf2-
ARE pathway by modifying cysteine residues on Keap-1, 
either by acting as electrophilic Michael acceptors, many 
after biotransformation to reactive quinones, or by upregu-
lating protein kinases that phosphorylate Nrf2 and facilitate 
its dissociation from Keap-1 [36–38]. These actions suggest, 
somewhat paradoxically, that phytochemicals may confer 
antioxidant effects indirectly and as a result of their initial 
pro-oxidant effects [26, 39]. Since the reactions needed to 
stimulate Nrf2 are possible at the low, sub-toxic concen-
trations typically reported for phytochemicals [26], this 
substantiates the notion that the antioxidant effects phyto-
chemicals are more likely to be indirect. Specifically, acti-
vating Nrf2 will upregulate synthesis of several antioxidant 
enzymes [40–42]. Given that oxidative stress and low grade 
inflammation underlie the pathogenesis of many degenera-
tive chronic diseases, Nrf2 has emerged as an attractive 
therapeutic target for health promotion and disease preven-
tion [30, 43].
The Nrf2 inducing effects of various phytochemicals have 
been well-described in the literature with activation of the 
Nrf2-ARE axis now recognized as the major mechanism 
by which phytochemicals mitigate pro-oxidative and pro-
inflammatory insults [27, 44]. However, most of the research 
reporting Nrf2 induction with phytochemicals has been con-
ducted in pre-clinical cell culture or animal models. These 
studies typically use supra-physiological doses that are not 
achievable with normal dietary intakes. In the few studies 
that have assessed the effect of dietary phytochemicals on 
Nrf2 activation in humans, conflicting findings have been 
reported [45–47]. As such, there is currently no consensus 
on the effectiveness of phytochemicals to activate Nrf2 in 
humans. Thus, the aim of the present systematic review was 
to evaluate the extant literature and determine the impact of 
dietary phytochemicals on Nrf2 activation in humans. This 
systematic review was conducted according to the Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA) guidelines [48]. Given the emerging beneficial 
health effects associated with Nrf2 activation, determining 
the effectiveness of dietary components on its activation is 
a critical step in understanding how the Nrf2-ARE pathway 
can be therapeutically harnessed.
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Methods
The protocol for this systematic review was pre-regis-
tered on the PROSPERO database (Registration Number: 
CRD42020176121) and reported according to the PRISMA 
guidelines [48].
Search strategy
Medline, Embase and CAB abstracts were searched for arti-
cles from inception until March 2020. Our search strategy 
was based on a Population, Intervention, Comparator, Out-
come, Study design (PICOS) methodology (available in the 
Online Supplementary Material). Using Boolean logic and 
truncations, a comprehensive list of terms and keywords 
were searched that linked “phytochemical” and “Nrf2”. Our 
terms and key words were adapted from similarly designed 
review articles [49, 50]. Because over 60 terms were entered, 
these are not reproduced here but are available in the Online 
Supplementary Material. Search terms were applied to the 
full texts; non-English studies were included in our search.
The titles and abstracts of the articles were screened inde-
pendently by two investigators (TC and KBD). The relevant 
full texts were retrieved to assess eligibility according to 
the criteria outlined below. All full-text articles included 
were searched manually for any additional studies; one was 
identified from this search [51]. Another [52], was identi-
fied from a Google Scholar search performed at this stage. 
A flow diagram of our search strategy is depicted in Fig. 1.
Study selection
Inclusion criteria were: (1) adult participants (≥ 18 years); 
(2) administration of a dietary phytochemical (or a combina-
tion of phytochemical compounds); (3) reporting of pre to 
post changes in Nrf2 via any methods and in any tissue. No 
restrictions were added for study design, but we excluded 
studies in animals. The full text of articles deemed to meet 
these criteria were retrieved and independently screened 
for their eligibility by all investigators (see Online Supple-
mentary Material for list of studies excluded). All investiga-
tors agreed on the articles to be included in the systematic 
review.
Data extraction
Data were extracted by three authors (TC, SC and SB). The 
data were based on our PICOS (see Online Supplementary 
Material) and included type of participants and their age, 
the study design, the interventions, duration of intake, type 
of measurement (e.g., protein, gene expression etc.), tissue 
type, and outcome. Because of the wide inter-study hetero-
geneities in study design and interventions, a meta-analysis 
was deemed inappropriate. Extracted data is displayed in 
Table 1.
Risk of bias
Study quality was assessed with the Cochrane Risk of Bias 
Tool [53] from Review Manager 5.3 (Cochrane Collabora-
tion, UK). This was performed independently by two authors 
(TC and JA) and disagreements were resolved through dis-
cussion. Each study was rated as either low, unclear or high 
risk of bias according to the following criteria: random 
sequence generation, allocation concealment, blinding of 
participants and personnel, blinding of outcome assessment, 
incomplete outcome data, selective reporting, and “other” 




Results from our search strategy are presented in Fig. 1. We 
identified 2341 articles from three databases, which was 
reduced to 2123 after removing duplicates. After initial 
screening of abstracts and titles, we retrieved twenty-nine 
full texts; eleven were excluded and eighteen were deemed 
eligible and included in the review.
Study characteristics
Table 1 summarizes the studies examining the effects of 
phytochemicals on Nrf2. Across the 18 included studies, 
12 different phytochemicals were examined for Nrf2 activa-
tion. Only three individual phytochemicals were measured 
in more than one study; these were curcumin [54–56], res-
veratrol [45, 57, 58] and sulforaphane [46, 59, 60]. Other 
phytochemicals examined were soybean-isoflavones [62], 
lycopene [63], fish oil [63], and co-enzyme Q-10 [64]. The 
chemical structures of these phytochemicals are shown in 
Fig. 2. Some studies examined the effects of a whole food or 
fluid rich in phytochemicals; these included tart cherry juice 
[52], seed oils [65], bilberry [66], whole grape powder [47] 
and phytochemical enriched coffee [51, 61].
Three of the included studies were pretest–posttest quasi 
experimental designs with no placebo comparator [54, 55, 
66]; seven studies employed a randomized crossover design 
[45, 51, 58–60, 65, 67]; eight employed a randomized paral-
lel groups design [46, 52, 56, 57, 62–64].
In the included studies there was a total of 727 partici-
pants; average age ranged from 18 to 67 years. Nine trials 
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were performed in healthy, disease free adults [45, 51, 52, 
55, 59–61, 64, 66, 68]; three were in type 2 diabetics [54, 
56, 57]; one was in chronic obstructive pulmonary dis-
ease patients [46]; two were in obese adults [65, 67]; one 
was in prostate cancer patients [63]; one was in ischemic 
stroke patients [62] and one was in chronic kidney disease 
patients [58]. Of these trials, only two were performed 
in adults ≥ 65 years of age [52, 64]. Of the seven trials in 
patients, only three recorded the intake of concomitant medi-
cations [46, 54, 62].
The length of the dietary intervention ranged from a 
single dose (n = 4) to 24 weeks; however, only one was 
longer than 12 weeks [62]. The most common duration 
was four weeks (n = 6). There was wide heterogeneity in 
doses used, within and between supplements (Table 1).
Most studies (n = 14) measured Nrf2 activation in 
peripheral blood cells [45, 51, 54, 55, 57, 58, 60, 62, 
64–67, 69]. One measured Nrf2 in skeletal muscle [52]; 
one in prostate tissue [63]; one in skin [59]; one in nasal 
epithelial cells (as well as peripheral blood mononuclear 
cells; PBMCs) [60] and one in alveolar macrophages, 
bronchial epithelial cells and PBMCs [46].
Fifteen studies evaluated Nrf2 activation as gene 
expression [46, 47, 51, 52, 54, 55, 57–64, 66]; of these, 
three also measured protein levels [62, 64, 65]. One study 
Fig. 1  Flow diagram of the process used in selection of the trials included in this systematic review
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measured protein levels only [54] and two studies meas-
ured Nrf2-DNA binding activity [45, 56].
Phytochemicals examined in more than one trial
Coffee derived phytochemicals
Boettler et al. [61] reported that a four-week intake of 
500 ml/day of coffee enriched with chlorogenic acid or 
n-methylpyridinium increased Nrf2 gene expression in 
27 healthy young adults compared to a low polyphenol 
control diet. Similarly, Volz et al. [51] reported a signifi-
cant 1.4 fold increase in Nrf2 gene expression in healthy 
individuals who consumed 750 ml of a phytochemical 
rich coffee per day for four weeks versus a low polyphe-
nol control diet.
Curcumin
Yang et al. [54] showed that 500 mg of curcumin for 15 days 
significantly increased Nrf2 protein expression compared to 
baseline in type 2 diabetics. Similarly, in a pretest–posttest 
design in 12 healthy volunteers, Cheng et al. [55] found that 
4 g of curcumin stimulated a ~ 1.3 fold increase in Nrf2 gene 
expression 4–6 h post-intake. By contrast, another study [56] 
found no change to Nrf2-ARE binding activity in kidney 
disease patients who consumed 320 mg/day of curcumin 
for eight weeks.
Resveratrol
A cocktail of resveratrol (100 mg) and grape polyphenols 
(75 mg) significantly increased Nrf2-ARE binding activ-
ity at 3 h (~ 150%) and 5 h (~ 100%) post consumption in 
Fig. 2  Chemical structures of main phytochemicals in the included studies. Structures from PubChem; references can be found in the Online 
Supplementary Material
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10 healthy adults [45] In a randomized, crossover study, 
Saldanha et al. [58] found no change in Nrf2 gene expres-
sion (− 0.27 fold) with a four week intake of resveratrol 
(500 mg/day) in kidney disease patients. Another study 
reported a significant increase in Nrf2 gene expression in 
diabetic patients consuming 800 mg/day of resveratrol for 
2 months [57]. However, the reported values indicate that 
Nrf2 decreased with resveratrol supplementation (pre-inter-
vention; 6.32 ± 1.05 vs. post-intervention 5.62 ± 1.35) (see 
“Discussion” below section).
Sulforaphane
Duran et  al. [60] found no significant effect of a sul-
foraphane-rich broccoli sprout homogenate (200 g/day for 
three days) on Nrf2 gene expression (0.9 to − 12.6% change) 
in fifteen healthy young adults. Similarly, Wise et al. [46] 
found that four weeks of sulforaphane (25–150 μmoles/day) 
did not significantly modify Nrf2 gene expression (max 
average fold change 1.17) in chronic obstructive pulmonary 
disease patients. In contrast, Kerns et al. [59] reported an 
increase in total and phosphorylated Nrf2 expression from 
four healthy subjects who applied broccoli sprout extract 
(500 nmol/ml of sulforaphane) to their arm for seven days.
Phytochemicals measured in single trials
Kropat et al. [66] found that an anthocyanin-rich bilberry 
extract (10 g) significantly decreased Nrf2 gene expression 
2, 4 and 8 h post consumption (− 40 to − 60% of baseline) 
in female ileostomy probands and female healthy controls. 
Perez-Herrera et al. [65] examined whether adding 400 µg/
ml of phenolics to various seed oils would modify Nrf2 
activation after a meal. They found no significant differ-
ences in Nrf2 gene expression 2 and 4 h post-intake but 
a ~ 18 to 25% decrease in Nrf2 content (nuclear fraction) 
4 h post intake in the phenolic containing oils, compared 
to sunflower oil. Magbanua et al. [63] examined the effects 
of the carotenoid, lycopene (30 mg/day), and fish oil (3 g/
day) on Nrf2 gene expression in prostate tissue from prostate 
cancer patients. After 12 weeks, they found a significant 
increase in Nrf2 activation after both supplements compared 
to a placebo control. Yubero-Serrano et al. [64] reported a 
significant increase in cytosolic Nrf2 content (4 h post-food 
intake) in healthy individuals who consumed co-enzyme 
Q-10 (200 mg/day) alongside a Mediterranean diet for four 
weeks. In the same study, this intervention was also found 
to significantly reduce nuclear Nrf2 protein content and 
gene expression 4 h after a mixed macronutrient meal. A 
large randomized controlled trial [62] reported a significant 
increase in Nrf2 gene expression (~ 40%) and protein content 
(~ 30%) after a 24 week intake of isoflavones (80 mg/day) 
in ischemic stroke patients. Jackman et al. [52] found that 
a 2-week intake of anthocyanin rich cherry juice (60 ml/
day) had no effect on Nrf2 gene expression in skeletal mus-
cle from 16 healthy older adults. By contrast, four-week 
intake of an anthocyanin rich mixture of grape polyphenols 
increased Nrf2 gene expression (~ 1.2 fold) 3 h following a 
high fat, high carbohydrate meal [67].
Risk of bias
There was a large variation in study quality (Figs. 3 and 4). 
Only two [46, 58] of the eighteen trials were deemed to be 
sufficiently well conducted and reported to have a low risk of 
bias for all variables; neither of which reported an increase 
in Nrf2 activation after the intervention. Four studies had 
an unclear risk of bias for random sequence generation 
because of insufficient details were given or no randomiza-
tion appeared to be performed [45, 54, 55, 66]. Two studies 
were deemed to have a high risk of bias for sequence alloca-
tion because they did not randomize the treatment order; all 
participants had the control first and then the intervention 
after a washout period [51, 61]. All but three studies [46, 57, 
58] had an unclear or high risk of bias for allocation conceal-
ment because insufficient information was given. One study 
was deemed high risk for this variable because participants 
were told to avoid the intervention in the weeks leading up 
to the trial [55]. Nine studies had an unclear risk of bias for 
blinding of participants or personnel and blinding of out-
come because insufficient details were provided [45, 51, 54, 
55, 60–62, 65, 66]. One study had a high risk of bias because 
the assessors were not blinded to the intervention groups 
[59]. In four studies, it was unclear if there was attrition 
bias [51, 57, 61, 66]. One study was considered high risk 
because the number of participants enrolled did not match 
the number reported for the outcomes and no explanation 
was provided for this discrepancy [60]. Five studies were 
judged to have an unclear risk of bias for selective reporting 
due to insufficient information [51, 55, 59, 61, 66]; two stud-
ies were deemed to have an unclear risk for other bias due 
to funding sources [45, 52] and two for a poorly described 
study design [51, 61]. Three studies were deemed to have a 
high risk for other bias because the studies had no compara-
tor control [54, 55, 66].
Discussion
This is the first study to systematically review trials exam-
ining the effects of phytochemicals on Nrf2 activation in 
humans. Across 18 studies, 12 different phytochemicals were 
examined, of which curcumin, resveratrol and sulforaphane 
were the most frequent. More than half the studies found 
evidence of a Nrf2 inducing effect (n = 10); however, many 
of them had a high risk of bias and were poorly controlled. 
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Overall, this study found limited high-quality evidence of 
phytochemicals activating Nrf2 in humans.
There was wide heterogeneity in study quality in human 
trials assessing the influence of phytochemical administra-
tion on Nrf2 activation. Many studies had an unclear or 
high risk of bias as a result of inadequate randomization, 
allocation concealment and blinding procedures. Three tri-
als had an unclear or high risk of bias for most variables as 
they did not include a comparator control arm and instead 
employed pretest posttest quasi experimental designs [54, 
55, 66]. In all three studies, Nrf2 activation was measured 
as changes in gene expression before and after the interven-
tion only. These changes also might not translate to increases 
in Nrf2 protein content. Another limitation in many stud-
ies was low sample size. Eight studies contained less than 
twenty participants, and only two conducted a power analy-
sis for measuring Nrf2 [46, 58]. Many did not state a pri-
mary outcome and of those that did only two reported that 
it was Nrf2 [46, 58]. Thus, it would be reasonable to assume 
that many of the studies were not adequately powered to 
detect effects, and that the risk of type two errors was high. 
Another potential source of bias was the lack of dietary con-
trol in the studies. Habitual dietary intake is an important 
confounding factor when evaluating the nutrigenomic effects 
of phytochemicals [70]; however, it was largely ignored by 
the included studies. Many trials did not state whether par-
ticipants continued with their normal diet or altered their 
intakes during the study duration, and only three studies pro-
vided a detailed analysis of participants dietary intake [52, 
64, 67]. Finally, and as evident from Table 1, the reporting 
of methods was poor in some studies, with many providing 
inadequate information for replication. In summary, more 
appropriately powered studies are needed to evaluate the 
efficacy of dietary supplementation with phytochemicals 
to enhance Nrf2 activation with Nrf2 as the primary out-
come and, where possible, such studies should be conducted 
according to the Consolidated Standards of Reporting Trials 
(CONSORT) guidelines [71] so the highest quality evidence 
is obtained and reported.
In numerous in vitro studies, curcumin [72, 73] and res-
veratrol [74–76] have been shown to induce Nrf2 activation. 
Therefore, it is perhaps unsurprising that these were found to 
be the most studied polyphenols in humans. Curcumin has a 
Michael acceptor in the form of a α,β-unsaturated carbonyl 
group and thus the main mechanism by which it activates 
Nrf2 is by alkylating a protein thiol on the Keap-1-Nrf2 
binding complex, which allows Nrf2 to translocate to the 
nucleus to initiate antioxidant gene expression changes [34, 
38, 73, 77]. Resveratrol does not contain a Michael acceptor 
but instead likely acquires electrophilic and therefore Nrf2 
inducing capacity through oxidation to a reactive quinone 
[38].
In the three studies that administered curcumin, two were 
shown to increase Nrf2 activation and one had no effect. 
However, as mentioned above, neither of the studies report-
ing positive effects were randomized, placebo-controlled 
trials and therefore had a high risk of bias [54, 55]. For 
example, in one of these studies [55], Nrf2 expression was 
measured in twelve healthy volunteers before and after 4 g 
Fig. 3  Risk of bias summary for incldued studies
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of curcumin and a mixed macronutrient breakfast. While 
4–6 h post Nrf2 gene expression was ~ 1.3 fold higher com-
pared to baseline, there was no comparator group in this 
study and therefore it is not clear if this increase is a direct 
result of the curcumin. In contrast, the study by Jimenez 
and colleagues [56], was higher quality, employing a double 
blind, randomized, controlled design in a large cohort of 
diabetic patients. They found that eight weeks of curcumin 
(320 mg/day) had no effect on Nrf2 nuclear binding activ-
ity in PBMCs, despite curcumin lowering malondialdehyde, 
a marker of lipid peroxidation. This latter finding suggests 
that Nrf2 activation was not responsible for the lowering 
of oxidative stress and there must be other mechanisms by 
which curcumin functions as an antioxidant, perhaps by 
inhibiting oxidant producing immune cells [78, 79]. Never-
theless, a decrease in only one marker (malondialdehyde) is 
not deemed sufficient to verify oxidative stress [80]; there-
fore, these results should not be interpreted as evidence of 
a strong antioxidant effect [20, 81]. In summary, only one 
randomized controlled trial has examined the influence of 
curcumin administration on Nrf2 activation in humans and 
the results suggest that it was ineffective. Thus, there is 
currently no high-quality evidence showing that curcumin 
administration actives Nrf2 in humans.
Three studies examined the effects of resveratrol on Nrf2 
activation. Two of these reported that resveratrol increased 
Nrf2 activation, either via DNA binding activity after a sin-
gle dose [45] or via gene expression after two months of 
intake [57]. It should be noted that, in the former study, 
resveratrol was administered alongside 75 mg of undisclosed 
grape polyphenols and thus these effects cannot necessarily 
be ascribed to resveratrol. Confusingly, the findings in the 
latter study [57] do not match how the data was interpreted; 
the authors state that resveratrol increased Nrf2 expression 
and discuss these findings accordingly, yet the data they 
present shows that resveratrol decreased Nrf2. The authors 
were contacted to clarify these findings, but no response 
was received. In contrast to these studies, a study with 20 
chronic kidney disease patients found that four weeks of res-
veratrol (500 mg/day) had no effect on Nrf2 gene expression 
in PBMCs [58]. To explain their null findings, the authors 
speculated that the dose was too low, citing that the bioavail-
ability of resveratrol was probably compromised in patients 
with renal impairments. However, they did not measure tis-
sue levels of resveratrol or its metabolites to confirm this 
supposition. Overall, there is weak evidence that resvera-
trol increases Nrf2 activation in humans and therefore more 
high-quality research is required to corroborate or refute the 
in vitro and animal data.
In three studies the principal compound administered was 
sulforaphane, an isothiocyanate phytochemical present in 
cruciferous vegetables such as broccoli [82]. From a mecha-
nistic perspective, sulforaphane is an electrophile that can 
synthesize Nrf2 by reacting with the sulphur-rich cysteine 
residues on its repressor Keap-1 [83, 84]. Sulforaphane is 
perhaps the most well studied Nrf2-activating compound 
to date, partly owing to its superior bioavailability to other 
phytochemicals [82, 85]. There are now several clinical 
trials showing that sulforaphane attenuates inflammation 
and upregulates Nrf2 target genes in a range of patholo-
gies [86–88]. Intriguingly, these effects are largely ascribed 
to Nrf2 activation, yet we found little evidence that sul-
foraphane activates Nrf2 in humans. In the one study 
reporting positive effects [59], the findings were biased by 
a low sample size (4 subjects) and inadequate blinding of 
assessors. In addition, the authors did not state whether the 
Fig. 4  Risk of bias summary for individual studies
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increase in Nrf2 expression was statistically significant. In 
contrast, a broccoli sprout homogenate that contained an 
undisclosed amount of sulforaphane, and possibly other 
bioactive compounds, had no effect on gene expression in 
PBMCs or nasal epithelial cells (Duran et al. 2016). This 
study was also hampered by a small sample size (n = 15). 
Nonetheless, their findings are consistent with a well-con-
trolled clinical trial that found no effects of sulforaphane on 
Nrf2 activation in chronic obstructive pulmonary disease 
patients [46]. In this study, the authors speculated that per-
sistent redox and immune dysregulation in this population 
could have rendered the intervention less effective. This pos-
tulate is inconsistent with studies that found sulforaphane 
upregulated Nrf2 target genes in type 2 diabetics [88] and 
obese patients [87], who also have high levels of oxidative 
stress and low grade inflammation. However, as these stud-
ies did not measure Nrf2, it is possible that the cytoprotec-
tive effects reported with sulforaphane were independent of 
the Nrf2-ARE pathway. There is evidence that sulforaphane 
inhibits inflammation by blunting the pro-inflammatory tran-
scription factor nuclear factor kappa B (NF-κB), which pro-
vides some support for Nrf2-ARE independent effects of sul-
foraphane administration [89]. In summary, we found little 
evidence that sulforaphane activates Nrf2 in humans. Since 
there are several ongoing clinical trials with sulforaphane 
containing supplements, evidence to support the efficacy of 
sulforaphane as a Nrf2 activator in humans will hopefully 
become clearer over the next few years.
Two studies reported that daily intake of 500–750 ml 
of coffee made from beans enriched with chlorogenic acid 
or n-methylpyridinium increased Nrf2 gene expression in 
healthy young adults [51, 61]. Despite these positive find-
ings, it is important to note that both studies had a high risk 
of bias on the bases that no randomization was performed, 
there was no mention of double blinding, and the comparator 
arm was a low polyphenol diet with no information provided 
on what constituted a low polyphenol diet. Thus, while these 
studies are promising, well-controlled randomized trials 
are needed to confirm the efficacy of coffee consumption to 
increase Nrf2 activation.
The duration of supplementation varied widely across all 
studies, and there did not seem to be any specific pattern to 
discern the optimal length of the intervention. Indeed, Nrf2 
activation increased with a single dose [45] or after several 
weeks of intake in others [62, 63]. There is presently no 
consensus as to what the optimal dose or duration is for 
activating Nrf2 with phytochemicals or drugs [30, 82]. The 
optimal dose will not only depend on the quantity admin-
istered, but on its bioavailability, concentration reached in 
target cells, and the patients’ age and health status [30]. 
Well-controlled, multiple dose, pharmaco-kinetic studies 
in a variety of patient groups and tissues will be needed to 
acquire this knowledge.
It has been shown that Nrf2 activation declines with 
age [90, 91] and is downregulated in diseases such as type 
2 diabetes [92] and atherosclerosis [93]. In view of this, 
it could be speculated that older, diseased individuals are 
more likely to benefit from an intervention attempting to 
reestablish Nrf2 activation than young, healthy individu-
als, in whom Nrf2 activation is unlikely to be impaired. 
However, this might not be the case for patients on some 
medications. Indeed, it would be reasonable to assume that 
some medications which modulate redox signaling might 
interfere with Nrf2 activation, in which case it would be 
difficult to determine the independent effect of a phyto-
chemical intervention on this pathway in some patient pop-
ulations. Notwithstanding these potential confounders, this 
review found no clear evidence that age, health or medica-
tions modified the efficacy of the phytochemical interven-
tions on Nrf2 activation. Indeed, as shown in Table 1, find-
ings in young and healthy, or diseased individuals, were 
equally mixed, such that no discernable pattern emerged 
to suggest better or worse efficacy in a specific population 
or in those on concomitant medications. While Nrf2 was 
activated with isoflavones in stroke patients (almost half 
of whom were on medication) [62] and fish oil and lyco-
pene in prostate cancer patients [63], in what were large 
relatively well controlled trials, it would be premature to 
suggest these populations could benefit from these inter-
ventions based on findings from isolated studies. Equally, 
the null effects of curcumin in diabetic patients [56] or 
sulforaphane in chronic obstructive pulmonary disease 
patients [46] should be not seen as definitive evidence 
that they are ineffective in these diseases. Ultimately, there 
were too few studies in any one population to discern what 
diseases or conditions these phytochemicals can or cannot 
modify Nrf2 activation.
Interestingly, in three studies there was evidence that 
phytochemicals decreased Nrf2 activation [64–66]. These 
studies differed markedly in terms of study design, partici-
pants and compounds used (bilberry pomace, co-enzyme 
Q10, phenolic-rich seed oils) and thus an explanation for 
their effects is unclear. Many phytochemicals have anti-
inflammatory effects [94] and therefore one possible expla-
nation is that these compounds attenuated immune cell 
derived reactive species that activate Nrf2. However, this 
was not explored in either study. It is also possible that 
these phytochemicals promoted Nrf2 degradation; some-
what paradoxically, there is in vitro evidence that certain 
flavonoids can inhibit Nrf2 activation [95]. However, these 
observations remain contentious and the mechanisms have 
not been elucidated [96]. The ability of different phyto-
chemicals to attenuate Nrf2 activation clearly requires 
further research.
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Recommendations for future research
Based on the findings of this review, a number of recom-
mendations for future studies can be provided. Ideally, 
future trials will be randomized, placebo controlled and 
have a low risk of bias, like some in this review [46, 58, 
63]. Although most phytochemicals are generally recog-
nized as safe, it is important that trials record any adverse 
effects so that dosing regimens can be modified if neces-
sary. These studies are required before titration studies 
to determine optimal doses and durations are considered. 
Trials are needed in both healthy and diseased populations 
of different ages, and confounding factors such as dietary 
intake, medication, ethnicity, body mass, and physical 
activity levels should be accounted for in randomization 
and analysis. Stage of disease progression is also another 
important factor to consider. This is highlighted by the 
ongoing work in cancer, which suggests that Nrf2 can 
have both a positive and detrimental role in cancer sur-
vival depending on the stage of the disease [96, 97]. In 
terms of measurement, Nrf2 activation can be evaluated 
in PBMCs and other accessible tissues (nasal cells etc.) 
with relative ease through gene expression and/or pro-
tein content assays. An obvious caveat is that these cells 
might not reflect changes in the target tissue. However, 
at least in PBMCs, changes in immune and redox signal-
ing have been shown to strongly correlate with changes 
in several organs [98, 99]. Furthermore, Nrf2 is highly 
expressed in blood cells and therefore easily detectable 
[30]. A discussion of the methods used to quantify Nrf2 
in these matrices is beyond the scope of this review but 
measuring total and phosphorylated Nrf2 in nuclear and 
cytosolic fractions at the gene and protein level would pro-
vide the most comprehensive data. It might also be useful 
to evaluate Nrf2 effects at multiple time-points to avoid 
missing any transient changes. In the present review, sin-
gle dose studies showed that changes in gene and protein 
expression were not evident until 3–5 h post-intake and 
thus the timing of Nrf2 measurement might be an impor-
tant consideration for future research. It would also be 
useful to measure Nrf2 activation alongside downstream 
genes such as superoxide dismutase, catalase, glutathione 
peroxidase, glutathione s-transferase, heme oxygenase 1, 
glutathione and thioredoxin, which participate in cellular 
defense and have longer half-lives than Nrf2 [30]. Vari-
ous phytochemicals have been shown to upregulate these 
and other Nrf2 target genes in humans [86–88, 100, 101]; 
however, as highlighted by this review, few studies also 
include measures of Nrf2, meaning these effects cannot 
be causally linked to activation of the Nrf2-ARE path-
way. Many of the target genes such as heme oxygenase 
1 and catalase can be upregulated by Nrf2-independent 
pathways [102–105], which could explain, at least in part, 
why some of the included studies report a disparity in the 
activation of Nrf2 and Nrf2 target genes [51, 57, 64–66]. 
In addition, systemic concentrations of the phytochemicals 
administered and where relevant its metabolites should be 
measured using appropriate techniques (e.g., liquid chro-
matography–mass spectroscopy). The bioavailability of 
the dietary phytochemicals was overlooked by almost all 
studies in this review and should be prioritized in future 
trials. Finally, future studies should explore the potential 
synergistic, additive or antagonistic effects of different 
phytochemical combinations on Nrf2 activation. There 
is growing evidence that the biological activity of some 
phytochemicals, such as curcumin, is augmented by the 
addition of piperine, partly as a result of improved bio-
availability [106, 107]. Combinations such as these are 
worth exploring in future studies. Collectively, the out-
lined measures will help to ensure the data collected is 
high quality and able to advance our current understanding 
of how dietary phytochemical interventions modulate Nrf2 
activation in humans.
Conclusions
The current review provides a systematic summary of 
the evidence for administration of dietary phytochemi-
cals to induce Nrf2 in humans. According to our review, 
there is insufficient high-quality evidence indicating that 
phytochemicals activate Nrf2 in humans. While many 
phytochemicals increased Nrf2 activation in single stud-
ies, it would be premature to single out any one specific 
compound due to the overall paucity of well controlled 
clinical trials and the diverse findings reported. Of critical 
importance moving forward is that future studies examine 
if the positive findings reported in cell culture and ani-
mal studies are translatable to humans. The pleiotropic 
role of Nrf2 in modulating system wide cytoprotective 
defenses means targeting this single transcription factor 
has the potential to improve health outcomes in a myriad 
of pathologies. While phytochemicals are unlikely to be 
as potent as the pharmacological agents currently being 
developed to activate Nrf2, they could play an important 
role as cost-effective, complementary, or preventative ther-
apies. We hope these findings provide researchers with 
the impetus to conduct high quality human intervention 
studies examining the effects of dietary phytochemicals 
on Nrf2 activation.
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